BRUKER CORPORATION Defined Benefit Plan, Expected Return (Loss) on Plan Assets
BRUKER CORPORATION (BRKR) reported Defined Benefit Plan, Expected Return (Loss) on Plan Assets of $8.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan
us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets · last filed 2026-02-27
- BRUKER CORPORATION defined benefit plan, expected return (loss) on plan assets for the quarter ending 2011-12-31 was $1.20M, a 71.43% increase year-over-year.
- BRUKER CORPORATION defined benefit plan, expected return (loss) on plan assets for the quarter ending 2011-09-30 was $1.10M, a 22.22% increase year-over-year.
- BRUKER CORPORATION defined benefit plan, expected return (loss) on plan assets for the quarter ending 2011-06-30 was $1.00M, a 11.11% increase year-over-year.
- BRUKER CORPORATION defined benefit plan, expected return (loss) on plan assets for the quarter ending 2010-12-31 was $700.00K.
- BRUKER CORPORATION defined benefit plan, expected return (loss) on plan assets for fiscal 2025 was $8.60M, a 65.38% increase from fiscal 2024.
- BRUKER CORPORATION defined benefit plan, expected return (loss) on plan assets for fiscal 2024 was $5.20M, a 18.18% increase from fiscal 2023.
- BRUKER CORPORATION defined benefit plan, expected return (loss) on plan assets for fiscal 2023 was $4.40M, a 158.82% increase from fiscal 2022.
- BRUKER CORPORATION defined benefit plan, expected return (loss) on plan assets for fiscal 2022 was $1.70M, a 5.56% decline from fiscal 2021.
| Period end | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 3 month | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 6 month | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 9 month | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $8.60M 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $5.20M 10-K · filed 2026-02-27 | |||
| 2023-12-31 | $4.40M 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $1.70M 10-K · filed 2025-03-03 | |||
| 2021-12-31 | $1.80M 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $2.50M 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $2.00M 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $1.90M 10-K · filed 2021-03-01 | |||
| 2017-12-31 | $1.70M 10-K · filed 2020-03-27 | |||
| 2016-12-31 | $1.80M 10-K · filed 2019-03-01 | |||
| 2015-12-31 | $2.30M 10-K · filed 2018-03-16 | |||
| 2014-12-31 | $4.10M 10-K · filed 2017-03-01 | |||
| 2013-12-31 | $3.80M 10-K · filed 2016-02-29 | |||
| 2012-12-31 | $4.00M 10-K · filed 2015-02-27 | |||
| 2011-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $2.30M derived: sum of 2 quarters · filed 2014-02-27 | $3.30M derived: sum of 3 quarters · filed 2014-02-27 | $4.10M 10-K · filed 2014-02-27 |
| 2011-09-30 | $1.10M 10-Q · filed 2011-11-09 | $2.10M derived: sum of 2 quarters · filed 2011-11-09 | $2.90M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $1.00M 10-Q · filed 2011-08-09 | $1.80M 10-Q · filed 2011-08-09 | ||
| 2010-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $1.60M derived: sum of 2 quarters · filed 2013-02-28 | $2.50M derived: sum of 3 quarters · filed 2013-02-28 | $3.40M 10-K · filed 2013-02-28 |
| 2010-09-30 | $900.00K 10-Q · filed 2011-11-09 | $1.80M derived: sum of 2 quarters · filed 2011-11-09 | $2.70M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $900.00K 10-Q · filed 2011-08-09 | $1.80M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $3.50M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |